ロード中...
In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator
Evidence has shown that downstream signaling by mu opioid receptor (MOR) agonists that recruit β-arrestin2 may lead to the development of tolerance. Also, it has been suggested that opioid receptor desensitization and cyclic AMP overshoot contributes to the development of tolerance and occurrence of...
保存先:
| 出版年: | Eur J Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890425/ https://ncbi.nlm.nih.gov/pubmed/29530590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2018.03.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|